Life expectancy for people with a history of both cardiovascular disease and diabetes is substantially lower than for people with just one condition or no disease, a new study harnessing the power of ‘big data’ has concluded.
A protein that targets the effects of a faulty gene could offer the first treatment targeting the major genetic cause of pulmonary arterial hypertension, according to research funded by the British Heart Foundation (BHF) and carried out at the ̽»¨Ö±²¥ of Cambridge.
Screening to identify type 2 diabetes followed by early treatment could result in substantial health benefits, according to new research published today in Diabetes Care that combined large scale clinical observations and innovative computer modelling.
New research suggests it may be possible to predict an infant’s progress following surgery for congenital heart disease by analysing a number of important small molecules in the blood.
A simple supplement could be a safe and cost-effective way of reducing heart disease in individuals born with a low birth weight, suggests research from the ̽»¨Ö±²¥ of Cambridge. ̽»¨Ö±²¥study, carried out in rats, also raises the possibility of developing a blood test to indicate how much damage there is in the aortas of these individuals.
̽»¨Ö±²¥increasing urbanisation of rural areas in sub-Saharan Africa could lead to an explosion in incidences of heart disease and diabetes, according to a new study carried out in Uganda which found that even small changes towards more urban lifestyles was associated with increased risk of cardiovascular and metabolic diseases.
A daily supplement of an extract found in tomatoes may improve the function of blood vessels in patients with cardiovascular disease, according to new research from the ̽»¨Ö±²¥ of Cambridge.
Promising new technique for creating stem cells using a routine blood sample.
First use of PET and CT to look at disease processes leading to heart attack.
© 2025 ̽»¨Ö±²¥ of Cambridge